WO2002040645A3 - Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung - Google Patents

Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung Download PDF

Info

Publication number
WO2002040645A3
WO2002040645A3 PCT/EP2001/012852 EP0112852W WO0240645A3 WO 2002040645 A3 WO2002040645 A3 WO 2002040645A3 EP 0112852 W EP0112852 W EP 0112852W WO 0240645 A3 WO0240645 A3 WO 0240645A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
mesenschymal
stem cells
derivable therefrom
cell constructs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/012852
Other languages
English (en)
French (fr)
Other versions
WO2002040645A2 (de
Inventor
Rosemarie Daig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7663304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002040645(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to AU2002221814A priority Critical patent/AU2002221814A1/en
Priority to DE50111055T priority patent/DE50111055D1/de
Priority to EP01996595A priority patent/EP1337624B1/de
Publication of WO2002040645A2 publication Critical patent/WO2002040645A2/de
Publication of WO2002040645A3 publication Critical patent/WO2002040645A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0627—Hair cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/335—Glucagon; Glucagon-like peptide [GLP]; Exendin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)

Abstract

Die Erfindung betrifft Zellkonstrukte enthaltend eine Polymermatrix und mesenchymale Stammzellen aus Haarfollikeln oder daraus ableitbarer Zellen des Bindegewebes sowie Verfahren zur Herstellung solcher Zellkonstrukte und die Verwendung dieser Zellkonstrukte.
PCT/EP2001/012852 2000-11-14 2001-11-07 Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung Ceased WO2002040645A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002221814A AU2002221814A1 (en) 2000-11-14 2001-11-07 Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof
DE50111055T DE50111055D1 (de) 2000-11-14 2001-11-07 Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung
EP01996595A EP1337624B1 (de) 2000-11-14 2001-11-07 Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056465A DE10056465A1 (de) 2000-11-14 2000-11-14 Zellkonstrukte erhältlich aus mesenchymalen Stammzellen und davon ableitbaren Zellen und ihre Verwendung
DE10056465.8 2000-11-14

Publications (2)

Publication Number Publication Date
WO2002040645A2 WO2002040645A2 (de) 2002-05-23
WO2002040645A3 true WO2002040645A3 (de) 2002-12-05

Family

ID=7663304

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/012852 Ceased WO2002040645A2 (de) 2000-11-14 2001-11-07 Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung

Country Status (5)

Country Link
EP (1) EP1337624B1 (de)
AT (1) ATE340253T1 (de)
AU (1) AU2002221814A1 (de)
DE (2) DE10056465A1 (de)
WO (1) WO2002040645A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666675B2 (en) 2001-09-20 2010-02-23 Anticancer, Inc. Nestin-expressing hair follicle stem cells
DE10224982A1 (de) * 2002-06-05 2003-12-24 Rolf Hoffmann Mesenchymale Stammzellen des Haarfollikels und deren Verwendung
US7597885B2 (en) 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
WO2007062386A2 (en) 2005-11-22 2007-05-31 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
SG11201506312TA (en) 2013-02-12 2015-09-29 Replicel Life Sciences Inc Compositions and methods for treating and repairing tendons
WO2015123477A1 (en) 2014-02-12 2015-08-20 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
CN103948966B (zh) * 2014-05-07 2015-10-28 柳毅 维甲酸羟基磷灰石仿生复合物的制备方法及该仿生复合物
CN104894064A (zh) * 2015-07-08 2015-09-09 河南中科干细胞基因工程有限公司 一种用于培养间充质干细胞的培养基
JP6813923B1 (ja) * 2020-06-16 2021-01-13 バイオチューブ株式会社 体性幹細胞集積組織構造体及びその製造器具

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001423A1 (en) * 1993-07-01 1995-01-12 The Trustees Of The University Of Pennsylvania Methods of culturing and modulating the growth of hair follicular stem cells
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5800811A (en) * 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
US5968546A (en) * 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387369B1 (en) * 1997-07-14 2002-05-14 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1995001423A1 (en) * 1993-07-01 1995-01-12 The Trustees Of The University Of Pennsylvania Methods of culturing and modulating the growth of hair follicular stem cells
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5800811A (en) * 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
US5968546A (en) * 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
REYNOLDS A J ET AL: "HAIR FOLLICLE STEM CELLS? A DISTINCT GERMINATIVE EPIDERMAL CELL POPULATION IS ACTIVATED IN VITRO BY THE PRESENCE OF HAIR DERMAL PAPILLA CELLS", JOURNAL OF CELL SCIENCE, ESSEX, GB, vol. 99, no. 2, June 1991 (1991-06-01), pages 373 - 385, XP001010318 *
YOUNG RANDELL G ET AL: "Use of mesenchymal stem cells in a collagen matrix for achilles tendon repair.", JOURNAL OF ORTHOPAEDIC RESEARCH, vol. 16, no. 4, July 1998 (1998-07-01), pages 406 - 413, XP002204291, ISSN: 0736-0266 *

Also Published As

Publication number Publication date
ATE340253T1 (de) 2006-10-15
WO2002040645A2 (de) 2002-05-23
AU2002221814A1 (en) 2002-05-27
DE10056465A1 (de) 2002-07-18
EP1337624B1 (de) 2006-09-20
DE50111055D1 (de) 2006-11-02
EP1337624A2 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
WO2004078917A3 (en) Expansion of renewable stem cell populations using modulators of pi 3-kinase
WO2002016620A3 (en) Modulation of stem cell differentiation
WO2003020884A3 (en) Method for rapid generation of mature dendritic cells
WO2002018546A3 (en) Plasma-derived-fibrin-based matrices and tissue
JP2005532079A5 (de)
AU2002245117A1 (en) In vitro-derived adult pluripotent stem cells and uses therefor
WO2002067812A3 (en) Tympanic membrane patch
GB0309765D0 (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
EP2281832A3 (de) Polynukleotide, die für antigene HIV-Polypeptide des C-Typs codieren, Polypeptide und ihre Verwendung
AU2001242299A1 (en) Fungal transcriptional activator useful in methods for producing polypeptides
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
AU2002221033A1 (en) Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
ATE365203T1 (de) Hefe-extraktlösung, ihre herstellung und verwendung zur zellfreien proteinsynthese
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
WO2001092473A3 (de) Verfahren zur kultivierung von knorpelersatz und biomatrix nach diesem verfahren hergestellt
WO2003068961A3 (en) Method to modify differentiation of pluripotential stem cells
WO2003080816A3 (en) Stem cell culture
WO2002033060A3 (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
WO2001079472A3 (en) Nucleic acid sequences to proteins involved in tocopherol synthesis
WO2002040645A3 (de) Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung
WO2003070905A3 (en) Electroporation methods for introducing bioactive agents into cells
WO2002083888A3 (en) The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
WO2002077627A3 (en) Patch-clamping and its use in analysing subcellular features
WO2005054439A3 (en) Small interfering rna (sirna)-mediated heritable gene manipulation in plants
WO2001072970A3 (en) Methods to prepare and use epidermal stem cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001996595

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001996595

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2001996595

Country of ref document: EP